IndraLab

Statements


ATG7 inhibits USP28. 1 / 1
| 1

reach
"The results showed that with 5-aza-2 '-deoxycytidine treatment, the inhibition of usp28 promoter activity was reversed, USP28 protein and its downstream CD44s protein abundance were also increased by ATG7 knockdown (XREF_FIG and XREF_FIG)."